CYTOKINETICS
CYTOKINETICS operates in Diversified Metals & Mining.
Market Cap & Net Worth: CYTOKINETICS (KK3A)
CYTOKINETICS (MU:KK3A) has a market capitalization of $522.93K (€509.45K) as of March 19, 2026. Listed on the MU stock exchange, this Germany-based company holds position #37445 globally and #4826 in its home market, demonstrating a 4.88% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying CYTOKINETICS's stock price €54.85 by its total outstanding shares 9288 (9.29K).
CYTOKINETICS Market Cap History: 2015 to 2026
CYTOKINETICS's market capitalization history from 2015 to 2026. Data shows growth from $91.61K to $522.93K (23.64% CAGR).
CYTOKINETICS Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how CYTOKINETICS's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.09x
CYTOKINETICS's market cap is 0.09 times its annual revenue
0.01x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $111.74K | $106.41 Million | $16.45 Million | 0.00x | 0.01x |
| 2017 | $67.05K | $13.37 Million | -$127.79 Million | 0.01x | N/A |
| 2018 | $53.10K | $31.50 Million | -$106.29 Million | 0.00x | N/A |
| 2019 | $85.80K | $26.87 Million | -$121.69 Million | 0.00x | N/A |
| 2020 | $161.12K | $55.83 Million | -$127.29 Million | 0.00x | N/A |
| 2021 | $388.98K | $70.43 Million | -$215.31 Million | 0.01x | N/A |
| 2022 | $409.96K | $94.59 Million | -$388.95 Million | 0.00x | N/A |
| 2023 | $715.04K | $7.53 Million | -$526.24 Million | 0.09x | N/A |
Competitor Companies of KK3A by Market Capitalization
Companies near CYTOKINETICS in the global market cap rankings as of March 19, 2026.
Key companies related to CYTOKINETICS by market ranking:
- BERKSHIRE HATH-A (BE:BRH): Ranked #2328 globally with a market cap of $6.43 Billion USD ( €6.27 Billion EUR).
- BERKSHIRE HATH-A - Dusseldorf Stock Exchang (DU:BRH): Ranked #2395 globally with a market cap of $6.17 Billion USD ( €6.02 Billion EUR).
- Itissalat Al-Maghrib (IAM) S.A (PINK:MAOTF): Ranked #3760 globally with a market cap of $3.25 Billion USD.
- NET ONE SYSTEMS (MU:NOX): Ranked #4660 globally with a market cap of $2.24 Billion USD ( €2.18 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #2328 | BERKSHIRE HATH-A | BE:BRH | $6.43 Billion | €634500.00 |
| #2395 | BERKSHIRE HATH-A - Dusseldorf Stock Exchang | DU:BRH | $6.17 Billion | €638000.00 |
| #3760 | Itissalat Al-Maghrib (IAM) S.A | PINK:MAOTF | $3.25 Billion | $14.80 |
| #4660 | NET ONE SYSTEMS | MU:NOX | $2.24 Billion | €1000000.00 |
CYTOKINETICS Historical Marketcap From 2015 to 2026
Between 2015 and today, CYTOKINETICS's market cap moved from $91.61K to $ 522.93K, with a yearly change of 23.64%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €522.93K | +3.49% |
| 2025 | €505.30K | +15.72% |
| 2024 | €436.65K | -38.93% |
| 2023 | €715.04K | +74.42% |
| 2022 | €409.96K | +5.39% |
| 2021 | €388.98K | +141.42% |
| 2020 | €161.12K | +87.78% |
| 2019 | €85.80K | +61.58% |
| 2018 | €53.10K | -20.80% |
| 2017 | €67.05K | -39.99% |
| 2016 | €111.74K | +21.97% |
| 2015 | €91.61K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of CYTOKINETICS was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $522.93K USD |
| MoneyControl | $522.93K USD |
| MarketWatch | $522.93K USD |
| marketcap.company | $522.93K USD |
| Reuters | $522.93K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.